Company intelligence / Profile preview

CorRen Medical

Eden Prairie, Minnesota, United Statescorrenmedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CorRen Medical has developed UltraSense, an AI-powered, hands-free ultrasound probe for early detection of peripheral artery disease. The system aims to provide fast, accurate PAD diagnosis at the point of care with minimal operator skill required. The company has finalized its superior probe design and is advancing toward regulatory approval; clinical results are not yet published but the technology is designed to improve accuracy and accessibility for PAD screening

Therapeutic areas: Cardiovascular
Modalities: DeviceAI-driven diagnostic systemUltrasound-based technology
Industry: Medical Imaging

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on CorRen Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CorRen Medical.

Explore the full profile